Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in ChildrenVéronique Minard‐Colin, Thomas G. Gross, Anne Aupérin et al.|New England Journal of Medicine|2020Cited by 308
Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot StudyElizabeth A. Raetz, Peter C. Adamson, William A. Wegener et al.|Journal of Clinical Oncology|2008Cited by 210
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium studyLars M. Wagner, Peter C. Adamson, John P. Perentesis et al.|Pediatric Blood & Cancer|2010Cited by 73
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for childrenAndrew D.J. Pearson, Gilles Vassal, Kimberly Stegmaier et al.|European Journal of Cancer|2020Cited by 25